These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N. Gynecol Oncol; 2007 Mar; 104(3):607-11. PubMed ID: 17092548 [Abstract] [Full Text] [Related]
4. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Sood AK, Sorosky JI, Gelder MS, Buller RE, Anderson B, Wilkinson EJ, Benda JA, Morgan LS. Cancer; 1998 May 01; 82(9):1731-7. PubMed ID: 9576296 [Abstract] [Full Text] [Related]
8. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI. Kim HS, Kim JW, Cho JY, Chung HH, Park NH, Song YS, Kim SH, Kang SB. Eur J Surg Oncol; 2009 Aug 01; 35(8):870-6. PubMed ID: 19179039 [Abstract] [Full Text] [Related]
10. Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study. Gadducci A, Zola P, Landoni F, Maggino T, Sartori E, Bergamino T, Cristofani R. Gynecol Oncol; 1995 Jul 01; 58(1):42-7. PubMed ID: 7789889 [Abstract] [Full Text] [Related]
11. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB. Acta Obstet Gynecol Scand; 2008 Jul 01; 87(11):1136-42. PubMed ID: 18951217 [Abstract] [Full Text] [Related]
15. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value]. Tan XJ, Lang JH, Shen K, Wang L, Wu M, Xu XY. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan 01; 43(1):9-12. PubMed ID: 18366924 [Abstract] [Full Text] [Related]
17. A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer. Rossi AC, Di Vagno G, Cormio G, Cazzolla A, Stefanelli S, D'Elia E, Selvaggi L. Arch Gynecol Obstet; 2004 May 01; 269(4):263-5. PubMed ID: 14745561 [Abstract] [Full Text] [Related]
19. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study. Veerman MM, van der Wurff AA, van de Water M, Kruitwagen RF, Feijen HW, Vos MC. Int J Gynecol Pathol; 2009 Sep 01; 28(5):432-41. PubMed ID: 19696612 [Abstract] [Full Text] [Related]